BDBM39596 2-[[4-ethyl-5-(2-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-1H-benzimidazole::2-[[[4-ethyl-5-(2-methoxyphenyl)-1,2,4-triazol-3-yl]thio]methyl]-1H-benzimidazole::MLS000083108::SMR000046462::cid_665365

SMILES C=CCCCOc1ccc(Nc2nc(Nc3ccc(OCC=C)c(OC)c3)ncc2C(F)(F)F)c(C(=O)NC)c1

InChI Key InChIKey=FQIZQPFHDUAPAR-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 39596   

TargetSerine/threonine-protein kinase ULK1(Human)
Salk Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 39596BDBM39596(US12594277, Compound 5)
Affinity DataIC50: 20nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2026
Entry Details
US Patent